WellQuest Medical & Wellness Corporation

WEQL · OTC
Analyze with AI
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Valuation
PEG Ratio-0.08-0.050.310.02
FCF Yield-11.20%-22.93%-97.77%-240.55%
EV / EBITDA-31.94-28.36-24.17-12.91
Quality
ROIC-23.19%-18.58%-15.73%-16.07%
Gross Margin8.37%8.27%2.83%2.61%
Cash Conversion Ratio-0.090.082.410.36
Growth
Revenue 3-Year CAGR0.06%12.36%8.61%3.74%
Free Cash Flow Growth83.62%86.85%58.21%-422.51%
Safety
Net Debt / EBITDA-30.66-25.19-19.73-10.09
Interest Coverage-1.23-1.59-1.83-3.79
Efficiency
Inventory Turnover0.0043.6143.8343.87
Cash Conversion Cycle-10.960.4319.41-5.86